Rns22 Apr 2020 08:18
TURKU - FINLAND- Faron Pharmaceuticals Oy ("Faron" or the "Company") (First North: FARON, AIM: FARN), the clinical stage biopharmaceutical company, is pleased to announce that further to the Launch Notice, both the Nordic Bookbuild and the UK Bookbuild are now closed. The Placing was significantly oversubscribed and comprises the issue of 2,719,002 Nordic Placing Shares at the Nordic Issue Price of €4.00 per Nordic Placing Share (representing a discount of 7.6 per cent. to the closing price of €4.33 per existing ordinary share on 21 April 2020 on Nasdaq First North) and up to 780,998 UK Placing Shares at the equivalent UK Issue Price of £3.48 per UK Placing Share. Subject to all conditions being met, the aggregate gross proceeds of the Placing will be up to €14 million (£12.18 million) before expenses. Binding commitments have been received for the Nordic Placing, however, as set out in the Launch Notice, the UK Placing remains subject to, inter alia, legally binding commitments being received ("UK Placee Condition"). A further announcement will be made when the UK Placee Condition has been met, expected to be on or before 23 April 2020. Both the Nordic Placing and the UK Placing remain subject to, inter alia, the Placing Shares being issued and being registered at the Finnish Trade Register ("Registration"). The Placing Shares will confer a right to dividends and other shareholder rights from their Registration. Registration is expected to occur in tranches as follows:· 1,892,763 Placing Shares (comprising the "First Issue Shares") are expected to be issued and registered on or about 23 April 2020;· 950,000 Placing Shares (comprising the "Second Issue Shares") are expected to be issued and registered on or about 24 April 2020; and· 657,237 Placing Shares and, to the extent that the Broker Option is exercised, any Option Shares to be issued (comprising the "Third Issue Shares") are expected to be issued and registered on or about 28 April 2020. Following Registration of each tranche of shares as above, the new Ordinary Shares will subsequently be entered in the book-entry system maintained by Euroclear Finland Oy and registered in the book-entry accounts of each investor. Applications will be made to the Nasdaq Helsinki Ltd and London Stock Exchange for admission to Nasdaq First North Growth Market Finland and AIM, respectively, of the Placing Shares. Subject to all conditions being met, First Admission is expected to occur on or around 8.00 a.m. BST/ 10.00 a.m. EEST on 24 April 2020, Second Admission is expected to occur on or around 8.00 a.m. BST/ 10.00 a.m. EEST on 27 April 2020 and Third Admission, is expected to occur on or around 8.00 a.m. BST/ 10.00 a.m. EEST on 29 April 2020.